MacroGenics Announces Sale of TZIELD™ Royalty Interest for up to $200 MillionGlobeNewsWire • 03/08/23
MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference CallGlobeNewsWire • 03/07/23
Strength Seen in MacroGenics (MGNX): Can Its 25.7% Jump Turn into More Strength?Zacks Investment Research • 02/20/23
MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers SymposiumGlobeNewsWire • 02/13/23
MacroGenics Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of DirectorsGlobeNewsWire • 01/04/23
Can MacroGenics (MGNX) Climb 74% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 12/05/22
MacroGenics (MGNX) Recently Broke Out Above the 20-Day Moving AverageZacks Investment Research • 12/02/22
Wall Street Analysts Believe MacroGenics (MGNX) Could Rally 123%: Here's is How to TradeZacks Investment Research • 11/17/22
MacroGenics Provides Corporate Update and Third Quarter 2022 Financial ResultsGlobeNewsWire • 11/03/22